NCT07239817 PENG Block + LIA For Endoprosthesis Surgery
| NCT ID | NCT07239817 |
| Status | Recruiting |
| Phase | — |
| Sponsor | ASST Gaetano Pini-CTO |
| Condition | Hip Fractures |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-12-09 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-12-09 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if a new local anesthesia technique can control pain as well as the standard spinal anesthesia for adults having hip endoprosthesis surgery. The main questions it aims to answer are: * Is the new local anesthesia technique as effective as standard spinal anesthesia in managing pain during the first two days after surgery? * Does the new technique allow participants to move their leg sooner after the operation? Researchers will compare the new local anesthesia technique (numbing medicine injected directly around the hip joint) to standard spinal anesthesia (a numbing injection in the back) to see if the new technique works just as well for pain control while possibly causing fewer side effects like nausea. Participants who join this study will be randomly placed into one of two groups. One group will receive the standard spinal anesthesia before their surgery. The other group will receive the new local anesthesia technique before their surgery. After the operation, researchers will track the amount of extra pain medicine each participant uses and will check their ability to move their hip, knee, and foot.
Eligibility Criteria
Inclusion Criteria: * Provision of signed and dated informed consent form. * Scheduled for hip endoprosthesis surgery for femoral fracture with an anterior approach. * Age 18 years or older. * Willing and able to comply with the study protocol. Exclusion Criteria: * Failure to provide informed consent. * Age less than 18 years. * Known allergy to local anesthetics or other medications used in the protocol. * Presence of infection at the planned injection site. * Pre-existing hip prosthesis or prior major surgery on the same hip (e.g., revision surgery). * ASA physical status class \> IV. * Administration of intraoperative opiates or conversion to general anesthesia.
Contact & Investigator
Romualdo Del Buono, MD
PRINCIPAL INVESTIGATOR
Unit of Anesthesia, Intensive Care and Pain Management, ASST Gaetano Pini, Milan, Italy;
Frequently Asked Questions
Who can join the NCT07239817 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hip Fractures. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07239817 currently recruiting?
Yes, NCT07239817 is actively recruiting participants. Contact the research team at romualdo.delbuono@asst-pini-cto.it for enrollment information.
Where is the NCT07239817 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT07239817 clinical trial?
NCT07239817 is sponsored by ASST Gaetano Pini-CTO. The principal investigator is Romualdo Del Buono, MD at Unit of Anesthesia, Intensive Care and Pain Management, ASST Gaetano Pini, Milan, Italy;. The trial plans to enroll 100 participants.